Celecoxib Capsule
Product Images NDC 70247-009

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Celecoxib (NDC 70247-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qingdao Baheal Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mg Bottle Label)

Principal Display Panel (100 mg Bottle Label)
Each capsule of Celecoxib contains 100 mg and should be stored between 15°C to 30°C (59°F to 86°F). Dispense in child-resistant containers. Dosage and use information is provided in the accompanying prescribing information. The product is manufactured by Qingdao BAHEAL Pharmaceutical Co. Ltd. and distributed in Hauppauge, NY by Aiping Pharmaceutical, Inc. The medication guide must be given to each patient. If you require more details, refer to the Batch No./Expiration Date.*
FDA Label Image

Principal Display Panel (200 mg Bottle Label)

Principal Display Panel (200 mg Bottle Label)
Celecoxib Capsules of 200 mg are contained in each capsule. They are to be stored in child-resistant containers at controlled room temperature not exceeding 30°C (86°F) or going below 15°C (59°F). Dispensing instructions are provided with the accompanying prescribing information for users' guidance. The distribution of the drug is handled by Aiping Pharmaceutical, Inc. in Hauppauge, NY, and it is manufactured by Qingdao BAHEAL Pharmaceutical of Qingdao, PR China. Pharmacists are advised to provide the enclosed medication guide to each patient. However, there is no information available about what the medication is for.*
FDA Label Image

Principal Display Panel (400 mg Bottle Label)

Principal Display Panel (400 mg Bottle Label)
This is a description of a medication called Celecoxib Capsules, containing 400 mg celecorib. It should be stored at a temperature of 26°C (77°F) with excursions permitted to 30°C (59° to 86°F). The dispense should be in a child-resistant container according to USP standards. Dosage and usage information can be found in the prescribing information included. The medication is manufactured by Qingdao BAHEAL Phamaceuteal Co Ltd and distributed by Aiping Phamceuica in Hauppauge, NY, with a revised date of 612016. The medication is available in 60 capsules with an enclosed Medication Guide for each patient. There is also a batch number included with an expiration date.*
FDA Label Image

Principal Display Panel (50 mg Bottle Label)

Principal Display Panel (50 mg Bottle Label)
Celecoxib Capsules containing 50mg of medication are to be stored within the range of 15°C and 30°C. This medication should be dispensed in a resistant container with a sufficient label, following the accompanying prescribing information. Aping Pharmaceutical, Inc. is responsible for the distribution of the medication. Pharmacists should provide the Medication Guide to patients upon dispensing. There is not enough information to determine the batch number or expiration date.*
FDA Label Image

Chemical Structure (Celecoxib 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.